Aptevo Therapeutics appoints Baker Tilly as new auditor after Moss Adams merger

Aptevo Therapeutics Inc.

Moss Adams merged with Baker Tilly effective June 3, 2025; Moss Adams resigned and Baker Tilly appointed for FY2025.
No disagreements or reportable events with Moss Adams during 2024/2023 and subsequent interim period.
Prior audit reports from Moss Adams included a going concern uncertainty explanatory paragraph.

item 4.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.